Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-785-7 | CAS number: 7320-34-5
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 17.63 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 500 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 440.79 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- The equation in Figure R.8 -3 of the guidance on information requirements and chemical safety assessment, Chapter R.8 was used to convert the chronic oral NOAEL into a chronic inhalation NOAEC. An absorption ratio of 1:2 was used as a worst-case scenario.
The equation in Figure R. 8-3 of the guidance on information requirements
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL, the default assessment factor, as a standard procedure, is 1
- AF for differences in duration of exposure:
- 1
- Justification:
- As work place data are available to show that long-term inhalation exposure of humans does not result in adverse effects, a reduced factor of 1 was applied.
- Justification:
- No assessment factor. An allometric scaling factor of 4 was not applied as differences between human and rat breathing rates and body weights were taken into account when correcting the NOEC.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor to take into account 'other differences'
- AF for intraspecies differences:
- 5
- Justification:
- Intraspecies factor for workers
- AF for the quality of the whole database:
- 2
- Justification:
- An additional assessment factor to take into account the deviations from the OECD guideline and uncertainties arising from the dataset was applied.
- AF for remaining uncertainties:
- 1
- Justification:
- Default value
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.35 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 500 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 217.39 mg/m³
- Explanation for the modification of the dose descriptor starting point:
The equation in Figure R.8 -3 of the guidance on information requirements and chemical safety assessment, Chapter R.8 was used to convert the chronic oral NOAEL into a chronic inhalation NOAEC. An absorption ratio of 1:2 was used as a worst-case scenario.
- AF for dose response relationship:
- 1
- Justification:
- When the starting point for the DNEL calculation is a NOAEL, the default assessment factor, as a standard procedure, is 1
- AF for differences in duration of exposure:
- 1
- Justification:
- As work place data are available to show that long-term inhalation exposure of humans does not result in adverse effects, a reduced factor of 1 was applied.
- Justification:
- An allometric scaling factor of 4 was not applied as differences between human and rat breathing rates and body weights were taken into account when correcting the NOEC.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default assessment factor to take into account 'other differences' .
- AF for intraspecies differences:
- 10
- Justification:
- Intraspecies factor for the general population.
- AF for the quality of the whole database:
- 2
- Justification:
- An additional assessment factor to take into account the deviations from the OECD guideline and uncertainties arising from the dataset was applied.
- AF for remaining uncertainties:
- 1
- Justification:
- Default value.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Inorganic Phosphate Group 2i Derived No Effect Level (DNEL) derivation
Inorganic phosphate group 2i(sodium and potassium pyrophosphates):
IP No |
Substance name |
CAS No |
EINECS No |
Classification (EU CLP) |
5 |
Disodium dihydrogenpyrophosphate |
7758-16-9 |
231-835-0 |
- Irritating to eyes , category 2 |
6 |
Trisodium hydrogen diphosphate |
14691-80-6 |
238-735-6 |
- Corrosive to eyes, Category 1 -Acute toxicity - Category 4 |
7 |
Tetrasodium pyrophosphate |
7722-88-5 |
231-767-1 |
- Corrosive to eyes, category 1 - Acute toxicity via the oral route, category 4 |
15 |
Tetrapotassium pyrophosphate |
7320-34-5 |
230-785-7 |
- Irritating to eyes , category 2 |
All members of the group are structurally similar ionic inorganic compounds with the anion only changing by the number of hydrogen atoms to account for changes in charge due to increase in cation numbers.
Progression through the group sees an increase in cation number from two to four followed by a change in cation from sodium to potassium. Both cations are group 1 alkali metals with the same ionic charge, similar chemical behaviour and both sodium and potassium are essential biological elements.
Available tests
Key study is a 90-day repeated dose toxicity oral study performed according to OECD 408 (deviations noted include: 5 day dosing regimen and no individual data reported). No indication of GLP compliance is reported but the study is considered to be of sufficient adequacy and reliability to be considered a reliability 2. Additional supporting data are available but lack data are not considered suitable for use in the derivation of DNELs.
Additionally, six teratology studies are also available, four on disodium dihydrogenpyrophosphate and two on tetrasodium pyrophosphate.
Table1: Overview of available sub toxicity studies with pyrophosphates
Study length |
Animal |
N(L)OAEL [mg/kg bw/day] |
Reference |
Reliability |
13 Week |
SD Rat |
500 mg/ kg bw/day (NOAEL) |
Seo DS et al, 2011 |
2 (KEY STUDY) |
13 week |
Rat |
0.6% in feed (LOEL) |
Shimoji Net al.1988 |
2 |
6/12 months |
Mouse |
1% in feed (LOEL) |
Omoto Met al.1986 |
4 |
16 weeks |
Rat |
1% in feed (LOEL) |
Datta PKet al.1962 |
2 |
72 hr |
Rat |
10% in feed (one dose only) |
CraigJM 1957 |
4 |
10 d |
Mouse |
335 |
Morgareidge K 1973 |
2 |
10 d |
Rat |
169 |
Morgareidge K 1973 |
2 |
5 d |
Hamster |
166 |
Morgareidge K 1973 |
2 |
13 d |
Rabbit |
128 |
Morgareidge K 1973 |
2 |
10 d |
Mouse |
130 |
Bailey DE and Morgareidge K 1974 |
2 |
10 d |
Rat |
138 |
Bailey DE and Morgareidge K 1974 |
2 |
Choice of endpoint
The Derived No Effect Level will use the NOAEL of 500 mg/kg bw/day from the key study in rats (Seo DS, 2011). See above for DNEL justifications. The starting point was not corrested for differences in molecular formula since the NOAEL is based on the effects of pyrophosphate.
References
SCF (1990). Reports of the Scientific Committee for Food (Twenty-fifth series), First series of food additives of various technological functions, Opinion expressed on 18 May 1990,: Commission of the European Communities
[1]Guidance on information requirements and chemical safety assessment Chapter R.8 Appendix R. 8-8
[2]Guidance on information requirements and chemical safety assessment Chapter R.8 Appendix R. 8-8
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
